An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells

Mart M Lamers1, Jelte van der Vaart2, Kèvin Knoops3

  • 1Viroscience Department, Erasmus University Medical Center, Rotterdam, The Netherlands.

The EMBO Journal
|December 7, 2020
PubMed

Insights

Researchers developed a human 2D air-liquid interface culture model to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This model successfully mimics host-virus interactions and can be used for drug screening against COVID-19.

Area of Science:

  • Pulmonology
  • Virology
  • Cell Biology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, leading to severe respiratory distress and potential fatality.
  • The alveolar epithelium is a primary target for SARS-CoV-2, but suitable models for studying these interactions are limited.

Purpose of the Study:

  • To establish and characterize a novel human 2D air-liquid interface (ALI) culture system for modeling SARS-CoV-2 infection.
  • To investigate the cellular targets and host responses within this ALI model upon SARS-CoV-2 infection.
  • To evaluate the potential of this model for antiviral drug screening.

Main Methods:

  • Development of a 2D ALI culture system using cells derived from 3D fetal lung bud tip organoids.
  • Characterization of the ALI model using confocal microscopy, electron microscopy, and single-cell mRNA expression analysis.
  • Infection of the ALI model with SARS-CoV-2 and assessment of viral replication and host response.

Main Results:

  • The ALI cultures comprised alveolar cells, basal cells, and neuroendocrine cells, mimicking human lung tissue.
  • SARS-CoV-2 readily infected surfactant protein C-positive alveolar type II-like cells, leading to significant viral titers.
  • Infection induced a type I/III interferon response, and treatment with interferon lambda 1 reduced viral replication.

Conclusions:

  • The developed human 2D ALI culture system serves as a representative experimental model for SARS-CoV-2 infection.
  • This model allows detailed study of virus-host interactions in the alveolar epithelium.
  • The system is suitable for high-throughput drug screening to identify potential COVID-19 therapeutics.